Skip to content

Bogota Financial Corp. BSBK Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Bank of America logo
Bank of AmericaBAC
12.8B0.0%
Wells Fargo & Company logo
Wells Fargo & CompanyWFC
$9B0.0%
PNC Financial Services logo
PNC Financial ServicesPNC
800M0.0%
JPMorgan Chase logo
JPMorgan ChaseJPM
M&T Bank logo
M&T BankMTB
Citigroup logo
CitigroupC

Other financials

Income statement

See full
Revenue$4.7M+5.9%
Net income$705.9K-3.4%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$27.9M+9.0%
Total debt$69.4M+97.3%
Total equity$142.1M+2.7%
Total assets$877.2M-5.7%

Cash flow

See full
Operating cash flow$702.6K+4,487%
CapEx$29.3K-19.1%
Free cash flow$673.3K+1,390%

Valuation

See full
Market cap$116.46M+15.2%
Enterprise value$157.92M+20.3%
P/E56.4×
P/S6.7×-0.4×

Profitability

See full
Net margin11.8%+8.5pp
FCF margin22%

Returns & leverage

See full
Return on equity1.5%+1.1pp
Debt / equity0.5×+0.2×

Where this comes from

Reported directly by Bogota Financial Corp. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Bogota Financial Corp.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bogota Financial Corp.'s common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bogota Financial Corp.'s common stock, shares authorized (in shares)?
Bogota Financial Corp. (BSBK) reported common stock, shares authorized (in shares) of $30M in Q1 2026.
How has Bogota Financial Corp.'s common stock, shares authorized (in shares) changed year-over-year?
Bogota Financial Corp.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $30M to $30M.
What is the long-term trend for Bogota Financial Corp.'s common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Bogota Financial Corp.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $30M to $30M.